BeStock  

Regencell Bioscience RGC

US equityMarket cap rank #2658Drug Manufacturers - Specialty & Generic
$4.18 −$0.18 (-4.13%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.18 0.00%
Open$4.43
Prev close$4.36
Day range$4.12 – $4.43
Volume111.1K
Market cap$2.07B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q4, ended Dec 2017

Revenue$861.60M+6.0% YoY
Operating profit$90.70M-4.5% YoY
Net profit$28.90M-46.4% YoY
Diluted EPS$0.19-44.1% YoY
Free cash flow$79.40M-22.8% YoY
Operating cash flow$154.30M

Revenue, last 8 quarters

$787.1MMar '16$785.9MJun '16$811.5MSep '16$812.6MDec '16$821.2MMar '17$764.2MJun '17$716.0MSep '17$861.6MDec '17

Net profit, last 8 quarters

$40.7MMar '16$33.6MJun '16$42.3MSep '16$53.9MDec '16$48.4MMar '17$23.6MJun '17$11.4MSep '17$28.9MDec '17

Diluted EPS by quarter

0.26Mar '160.21Jun '160.27Sep '160.34Dec '160.31Mar '170.15Jun '170.07Sep '170.19Dec '17

Free cash flow by quarter

$149.7MMar '16$-300.0KJun '16$-56.6MSep '16$102.8MDec '16$204.9MMar '17$-101.4MJun '17$-23.4MSep '17$79.4MDec '17

Annual revenue

$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25$0.0FY26

Profitability & balance sheet

Gross margin62.4%
Operating margin10.5%
Net margin3.4%
Return on equity-128.5%
Return on assets-114.2%
Return on invested capital-122.9%
Current ratio10.77
Liabilities / assets9.4%
Cash & investments$14.19M
Total debt$59,499.00
Net cash (debt)$14.13M

Income statement

Line item 2026 ANNUAL 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $11.72M $3.77M $4.74M $6.27M $7.62M
Selling and Admin Expenses $10.42M $2.82M $3.67M $4.69M $5.11M
-Selling & Marketing Expense $6,486.00 $8,014.00 $125,427.00 $262,664.00 $25,275.00
-General & Admin Expense $10.42M $2.81M $3.55M $4.43M $5.08M
Research & Development $1.30M $948,289.00 $1.07M $1.58M $2.51M
Operating Profit -$11.72M -$3.77M -$4.74M -$6.27M -$7.62M
Other Income (Expense) $22,520.00 $185,772.00 $373,505.00 $211,342.00 $23,215.00
Other Non-Operating Income (Expenses) $22,520.00 $185,772.00 $373,505.00 $211,342.00 $23,215.00
Pretax Profit -$11.70M -$3.58M -$4.36M -$6.06M -$7.59M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$11.70M -$3.58M -$4.36M -$6.06M -$7.59M
Profit from Continuing Operations -$11.70M -$3.58M -$4.36M -$6.06M -$7.59M
Minority Interests $0.00 $0.00 -$61,384.00 -$191,199.00 -$148,612.00
Net Income to Parent Company -$11.70M -$3.58M -$4.30M -$5.87M -$7.45M
Net Income to Common Stockholders -$11.70M -$3.58M -$4.30M -$5.87M -$7.45M
Basic EPS -$0.02 -$0.01 -$0.01 -$0.01 -$0.02
Diluted EPS -$0.02 -$0.01 -$0.01 -$0.01 -$0.02

Balance sheet

Line item 2026 ANNUAL 2026 Q4 2026 Q2 2025 ANNUAL 2025 Q4
Total Assets $14.73M $14.73M $3.01M $5.76M $5.76M
Total Current Assets $14.22M $14.22M $2.36M $4.90M $4.90M
Cash and Cash Equivalents & Short-Term Investments $14.19M $14.19M – $4.90M $4.90M
-Cash and Cash Equivalents $14.19M $14.19M – $2.42M $2.42M
-Short Term Investments $0.00 $0.00 – $2.48M $2.48M
Receivables $30,702.00 $30,702.00 – $5,798.00 $5,798.00
-Other Receivables $30,702.00 $30,702.00 – $5,798.00 $5,798.00
Total Non-Current Assets $506,402.00 $506,402.00 $656,170.00 $852,769.00 $852,769.00
Net PPE $430,732.00 $430,732.00 – $759,819.00 $759,819.00
-Gross PPE $1.37M $1.37M – $1.62M $1.62M
-Accumulated Depreciation -$938,959.00 -$938,959.00 – -$857,267.00 -$857,267.00
Non-Current Prepaid Assets $75,670.00 $75,670.00 – $92,950.00 $92,950.00
Total Liabilities $1.38M $1.38M $1.79M $895,308.00 $895,308.00
Total Current Liabilities $1.32M $1.32M – $663,673.00 $663,673.00
Payables $10,787.00 $10,787.00 – $2,539.00 $2,539.00
-Due to Related Parties Current $10,787.00 $10,787.00 – $2,539.00 $2,539.00
Current Accrued Expenses $1.07M $1.07M – $348,354.00 $348,354.00
Short-Term Debt and Capital Lease Obligation $236,312.00 $236,312.00 – $312,780.00 $312,780.00
-Current Capital Lease Obligation $236,312.00 $236,312.00 – $312,780.00 $312,780.00
Total Non-Current Liabilities $59,499.00 $59,499.00 – $231,635.00 $231,635.00
Long Term Debt and Capital Lease Obligation $59,499.00 $59,499.00 – $231,635.00 $231,635.00
-Long Term Capital Lease Obligation $59,499.00 $59,499.00 – $231,635.00 $231,635.00
Total Equity $13.35M $13.35M $1.22M $4.86M $4.86M
Stockholders' Equity $13.35M $13.35M $1.22M $4.86M $4.86M
Capital Stock $4,959.00 $4,959.00 – $4,945.00 $4,945.00
-Common Stock $4,959.00 $4,959.00 – $4,945.00 $4,945.00
Additional Paid-In Capital $50.29M $50.29M – $30.12M $30.12M
Retained Earnings -$36.90M -$36.90M – -$25.20M -$25.20M
Gains/Losses Not Affecting Retained Earnings -$45,262.00 -$45,262.00 – -$64,786.00 -$64,786.00
Minority Interests $0.00 $0.00 – $0.00 $0.00
Other Non-Current Assets – – $656,170.00 – –

Cash flow

Line item 2026 ANNUAL 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL
Operating Cash Flow -$7.70M -$3.11M -$4.00M -$4.96M -$5.27M
Net cash flow from continuing operations -$7.70M -$3.11M -$4.00M -$4.96M -$5.27M
Net Income from Continuing Operations -$11.70M -$3.58M -$4.36M -$6.06M -$7.59M
Depreciation & Depletion & Amortization $404,543.00 $392,743.00 $745,588.00 $769,687.00 $604,397.00
Other Non-Cash Items -$22,520.00 -$185,772.00 -$248,000.00 -$85,400.00 -$10,733.00
Change in Working Capital $398,805.00 $18,858.00 -$585,365.00 -$508,945.00 -$1.02M
-Change in Prepaid Assets -$11,242.00 $151,714.00 -$85,415.00 -$23,147.00 -$104,625.00
-Change in Payables and Accrued Expense $733,490.00 $217,122.00 -$34,880.00 $1,874.00 -$489,025.00
-Change in Other Current Liabilities -$323,443.00 -$349,978.00 -$465,070.00 -$487,672.00 -$430,421.00
Net cash flow from investing $2.50M $2.69M $5.24M $58,978.00 -$10.78M
Net Cash Flow from Continuing Investing Activities $2.50M $2.69M $5.24M $58,978.00 -$10.78M
Net PPE Purchase and Sale $0.00 -$152,689.00 -$5,376.00 -$26,422.00 -$780,876.00
Net Investment Purchase and Sale $2.50M $2.84M $5.25M $85,400.00 -$10.00M
Financing Cash Flow $16.95M $0.00 $102,282.00 $134,913.00 $22.41M
Net Cash Flow from Continuing Financing Activities $16.95M $0.00 $102,282.00 $134,913.00 $22.41M
Net Common Stock Issuance $18.62M $0.00 $0.00 – $22.67M
Proceeds from Stock Option Exercised $102,561.00 $0.00 $0.00 – –
Net Other Financing Charges -$1.78M – $102,282.00 $134,913.00 $164,000.00
Ending Cash Balance $14.19M $2.42M $2.96M $1.56M $6.42M
Net Change in Cash $11.75M -$427,360.00 $1.34M -$4.77M $6.36M
Beginning Cash Balance $2.42M $2.96M $1.56M $6.42M $59,413.00
Effect of Exchange Rate Changes $18,907.00 -$114,760.00 $53,221.00 -$83,145.00 $0.00
Free Cash Flow -$7.70M -$3.27M -$4.01M -$4.99M -$6.05M
Gain/Loss from Continuing Operations – – – $1,415.00 –
Net Issuance Payments Of Debt – – – – -$431,969.00

Discussion

No comments yet — be the first to weigh in on RGC.

Sign in to join the discussion.

Scroll to Top